StockData

Cartesian Therapeutics, Inc. (RNAC) stock

RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$6.08−0.27 (-4.25%)

Close on Nov 16, 2026Market cap $183.95MP/E –Yield –

Cartesian Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Cartesian Therapeutics's total assets was $318.63M at Jun 30, 2026. For fiscal 2025 it was $296.41M, down 31.9% from the year before. Over ten years it grew 21.3% a year on average. The highest annual figure on record is $435.02M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$296.41M-31.9%
FY2024Dec 31, 2024$435.02M+42.6%
FY2023Dec 31, 2023$305.05M+83.9%
FY2022Dec 31, 2022$165.89M+3.8%
FY2021Dec 31, 2021$159.88M-3.4%
FY2020Dec 31, 2020$165.44M+66.2%
FY2019Dec 31, 2019$99.57M+123.8%
FY2018Dec 31, 2018$44.48M-56.0%
FY2017Dec 31, 2017$101.10M+13.2%
FY2016Dec 31, 2016$89.30M+108.5%
FY2015Dec 31, 2015$42.82M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$318.63M-18.1%
Q1 FY2026Mar 31, 2026$288.39M-29.5%
Q4 FY2025Dec 31, 2025$296.41M-31.9%
Q3 FY2025Sep 30, 2025$372.68M-18.2%
Q2 FY2025Jun 30, 2025$388.89M+11.8%
Q1 FY2025Mar 31, 2025$409.13M+25.8%
Q4 FY2024Dec 31, 2024$435.02M+42.6%
Q3 FY2024Sep 30, 2024$455.32M+329.4%
Q2 FY2024Jun 30, 2024$347.74M+149.3%
Q1 FY2024Mar 31, 2024$325.21M+108.9%
Q4 FY2023Dec 31, 2023$305.05M+83.9%
Q3 FY2023Sep 30, 2023$106.03M-40.5%
Q2 FY2023Jun 30, 2023$139.51M-25.8%
Q1 FY2023Mar 31, 2023$155.69M+6.9%
Q4 FY2022Dec 31, 2022$165.89M+3.8%
Q3 FY2022Sep 30, 2022$178.27M+6.6%
Q2 FY2022Jun 30, 2022$188.07M+4.2%
Q1 FY2022Mar 31, 2022$145.70M-17.6%
Q4 FY2021Dec 31, 2021$159.88M-3.4%
Q3 FY2021Sep 30, 2021$167.16M-7.6%
Q2 FY2021Jun 30, 2021$180.52M+140.0%
Q1 FY2021Mar 31, 2021$176.75M+99.0%
Q4 FY2020Dec 31, 2020$165.44M+66.2%
Q3 FY2020Sep 30, 2020$181.00M+357.7%
Q2 FY2020Jun 30, 2020$75.21M+60.2%
Q1 FY2020Mar 31, 2020$88.80M+42.1%
Q4 FY2019Dec 31, 2019$99.57M+123.8%
Q3 FY2019Sep 30, 2019$39.54M-34.4%
Q2 FY2019Jun 30, 2019$46.95M-36.1%
Q1 FY2019Mar 31, 2019$62.48M-30.5%
Q4 FY2018Dec 31, 2018$44.48M-56.0%
Q3 FY2018Sep 30, 2018$60.32M-45.0%
Q2 FY2018Jun 30, 2018$73.44M-37.2%
Q1 FY2018Mar 31, 2018$89.94M+21.8%
Q4 FY2017Dec 31, 2017$101.10M+13.2%
Q3 FY2017Sep 30, 2017$109.72M+27.9%
Q2 FY2017Jun 30, 2017$117.03M–
Q1 FY2017Mar 31, 2017$73.86M–
Q4 FY2016Dec 31, 2016$89.30M–
Q3 FY2016Sep 30, 2016$85.78M–

More Cartesian Therapeutics figures

See a number that looks wrong?